Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 48,600 | 341,200 | 249,400 | 148,200 | 97,300 |
| Depreciation Amortization | 41,600 | 155,900 | 119,600 | 80,400 | 36,800 |
| Income taxes - deferred | -9,300 | -21,600 | -53,600 | -19,800 | 100 |
| Accounts receivable | 76,600 | -199,900 | -51,600 | -47,100 | -30,100 |
| Other Working Capital | 51,500 | 26,700 | 92,700 | -45,700 | -97,500 |
| Other Operating Activity | -53,600 | 367,200 | 180,500 | 127,800 | 64,400 |
| Operating Cash Flow | $155,400 | $669,500 | $537,000 | $243,800 | $71,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -74,700 | -364,800 | -301,300 | -193,100 | -103,900 |
| Net Acquisitions | N/A | -3,900 | -3,900 | -3,200 | -3,200 |
| Purchase Of Investment | -809,600 | -2,280,800 | -1,397,700 | -1,143,700 | -546,500 |
| Sale Of Investment | 697,600 | 2,127,800 | 1,387,800 | 785,600 | 241,800 |
| Other Investing Activity | 0 | 200 | -12,300 | -2,300 | 0 |
| Investing Cash Flow | $-186,700 | $-521,500 | $-327,400 | $-556,700 | $-411,800 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,300 | 22,500 | 22,500 | 10,100 | 10,100 |
| Common Stock Repurchased | N/A | -557,700 | -557,700 | 0 | N/A |
| Other Financing Activity | -1,100 | -17,300 | -16,300 | -9,100 | -4,800 |
| Financing Cash Flow | $11,200 | $-552,500 | $-551,500 | $1,000 | $5,300 |
| Exchange Rate Effect | 1,100 | -5,800 | -12,600 | -5,300 | -1,000 |
| Beginning Cash Position | 643,300 | 1,053,600 | 1,053,600 | 1,053,600 | 1,053,600 |
| End Cash Position | 624,300 | 643,300 | 699,100 | 736,400 | 717,100 |
| Net Cash Flow | $-19,000 | $-410,300 | $-354,500 | $-317,200 | $-336,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 155,400 | 669,500 | 537,000 | 243,800 | 71,000 |
| Capital Expenditure | -74,700 | -364,800 | -301,300 | -193,100 | -101,600 |
| Free Cash Flow | 80,700 | 304,700 | 235,700 | 50,700 | -30,600 |